{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:58:28Z","timestamp":1791107908145,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,17]],"date-time":"2013-08-17T00:00:00Z","timestamp":1376697600000},"content-version":"vor","delay-in-days":594,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Washington University Institute of Clinical and Translational Science"},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.virol.2011.10.023","type":"journal-article","created":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T00:54:32Z","timestamp":1321232072000},"page":"174-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature"],"prefix":"10.1016","volume":"422","author":[{"given":"Michelle C.","family":"Sabo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent C.","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart C.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Bukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daved H.","family":"Fremont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2011.10.023_bb0005","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1009482","article-title":"Boceprevir for previously treated chronic HCV genotype 1 infection","volume":"364","author":"Bacon","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2011.10.023_bb0010","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1128\/JVI.02200-09","article-title":"Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes","volume":"84","author":"Bankwitz","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0020","doi-asserted-by":"crossref","first-page":"41624","DOI":"10.1074\/jbc.M305289200","article-title":"Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor","volume":"278","author":"Bartosch","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2011.10.023_bb0015","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1128\/JVI.79.13.8217-8229.2005","article-title":"An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies","volume":"79","author":"Bartosch","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0025","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1128\/JVI.80.10.4940-4948.2006","article-title":"Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry","volume":"80","author":"Bertaux","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0030","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04079","article-title":"Adaptive immune responses in acute and chronic hepatitis C virus infection","volume":"436","author":"Bowen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.virol.2011.10.023_bb0035","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1086\/652803","article-title":"How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocides","volume":"201","author":"Ciesek","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2011.10.023_bb0040","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/428578","article-title":"Prospective evaluation of community-acquired acute-phase hepatitis C virus infection","volume":"40","author":"Cox","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2011.10.023_bb0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-065X.2008.00676.x","article-title":"The structural immunology of antibody protection against West Nile virus","volume":"225","author":"Diamond","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.virol.2011.10.023_bb0060","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.virol.2010.12.020","article-title":"Antibody-mediated neutralization of flaviviruses: a reductionist view","volume":"411","author":"Dowd","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virol.2011.10.023_bb0055","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1053\/j.gastro.2009.02.080","article-title":"Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus","volume":"136","author":"Dowd","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2011.10.023_bb0050","doi-asserted-by":"crossref","first-page":"e1002111","DOI":"10.1371\/journal.ppat.1002111","article-title":"A dynamic landscape for antibody binding modulates antibody-mediated neutralization of west Nile virus","volume":"7","author":"Dowd","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2011.10.023_bb0065","doi-asserted-by":"crossref","first-page":"18285","DOI":"10.1074\/jbc.M602706200","article-title":"High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI","volume":"281","author":"Dreux","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2011.10.023_bb0070","doi-asserted-by":"crossref","first-page":"15394","DOI":"10.1073\/pnas.93.26.15394","article-title":"Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein","volume":"93","author":"Farci","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2011.10.023_bb0075","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1053\/jhep.2000.9877","article-title":"Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV","volume":"32","author":"Forns","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2011.10.023_bb0080","doi-asserted-by":"crossref","first-page":"10999","DOI":"10.1128\/JVI.00526-10","article-title":"Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture","volume":"84","author":"Gastaminza","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0300-9084(03)00004-X","article-title":"Glycosylation of hepatitis C virus envelope proteins","volume":"85","author":"Goffard","year":"2003","journal-title":"Biochimie"},{"key":"10.1016\/j.virol.2011.10.023_bb0085","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1128\/JVI.79.13.8400-8409.2005","article-title":"Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins","volume":"79","author":"Goffard","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0340","series-title":"Fields Virology","first-page":"1154","article-title":"Flaviviruses","author":"Gubler","year":"2007"},{"issue":"1719\u20131728","key":"10.1016\/j.virol.2011.10.023_bb0100","first-page":"e1711","article-title":"Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion","volume":"135","author":"Haberstroh","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2011.10.023_bb0105","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1128\/JVI.74.22.10407-10416.2000","article-title":"Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes","volume":"74","author":"Hadlock","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0110","doi-asserted-by":"crossref","first-page":"11905","DOI":"10.1128\/JVI.01548-10","article-title":"Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions","volume":"84","author":"Helle","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0115","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nature04081","article-title":"Prospects for a vaccine against the hepatitis C virus","volume":"436","author":"Houghton","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.virol.2011.10.023_bb0120","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","article-title":"Telaprevir for previously untreated chronic hepatitis C virus infection","volume":"364","author":"Jacobson","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2011.10.023_bb0125","doi-asserted-by":"crossref","first-page":"e22808","DOI":"10.1371\/journal.pone.0022808","article-title":"Generation of a cell culture-adapted hepatitis C virus with longer half life at physiological temperature","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2011.10.023_bb0130","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1099\/0022-1317-83-9-2091","article-title":"Occupancy and mechanism in antibody-mediated neutralization of animal viruses","volume":"83","author":"Klasse","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0345","doi-asserted-by":"crossref","first-page":"e1000762","DOI":"10.1371\/journal.ppat.1000762","article-title":"The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule","volume":"6","author":"Krey","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2011.10.023_bb0140","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody","volume":"393","author":"Kwong","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.virol.2011.10.023_bb0145","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1128\/JVI.79.10.6023-6034.2005","article-title":"Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection","volume":"79","author":"Lavillette","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2011.10.023_bb0155","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.1073\/pnas.95.12.6774","article-title":"Antiviral agent blocks breathing of the common cold virus","volume":"95","author":"Lewis","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2011.10.023_bb0160","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1128\/jvi.68.6.3965-3970.1994","article-title":"Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature","volume":"68","author":"Li","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0350","series-title":"Fields Virology","first-page":"1102","article-title":"Flaviviridae: the viruses and their replication","author":"Lindebach","year":"2007"},{"key":"10.1016\/j.virol.2011.10.023_bb0170","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nature04077","article-title":"Unravelling hepatitis C virus replication from genome to function","volume":"436","author":"Lindenbach","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.virol.2011.10.023_bb0175","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.0403519101","article-title":"Neutralizing antibody response during acute and chronic hepatitis C virus infection","volume":"101","author":"Logvinoff","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2011.10.023_bb0180","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nsmb.1382","article-title":"Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins","volume":"15","author":"Lok","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2011.10.023_bb0185","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1128\/JVI.02782-06","article-title":"Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding","volume":"81","author":"McCaffrey","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0195","doi-asserted-by":"crossref","first-page":"9647","DOI":"10.1128\/JVI.00914-08","article-title":"Apolipoprotein c1 association with hepatitis C virus","volume":"82","author":"Meunier","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0355","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/infdis\/jir511","article-title":"Vaccine-Induced Cross-Genotype Reactive Neutralizing Antibodies Against Hepatitis C Virus","volume":"204","author":"Meunier","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2011.10.023_bb0200","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/432478","article-title":"Humoral immune response in acute hepatitis C virus infection","volume":"41","author":"Netski","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2011.10.023_bb0205","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.virol.2011.10.023_bb0210","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2011.10.023_bb0215","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1128\/JVI.01732-06","article-title":"Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein","volume":"80","author":"Oliphant","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0220","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2011.10.023_bb0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.virol.2009.08.037","article-title":"Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor","volume":"394","author":"Owen","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.virol.2011.10.023_bb0230","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1099\/0022-1317-82-8-1877","article-title":"Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2","volume":"82","author":"Owsianka","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0235","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1099\/vir.0.83386-0","article-title":"Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein","volume":"89","author":"Owsianka","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","article-title":"The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection","volume":"1","author":"Pierson","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2011.10.023_bb0245","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.virol.2011.10.023_bb0250","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection","volume":"364","author":"Poordad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2011.10.023_bb0255","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.vaccine.2003.09.010","article-title":"Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection","volume":"22","author":"Puig","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2011.10.023_bb0260","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1126\/science.280.5371.1949","article-title":"A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding","volume":"280","author":"Rizzuto","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.virol.2011.10.023_bb0265","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1084\/jem.20101907","article-title":"MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1","volume":"208","author":"Ruprecht","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2011.10.023_bb0270","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1128\/JVI.00586-11","article-title":"Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a post-attachment step","volume":"85","author":"Sabo","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0275","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2011.10.023_bb0280","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1073\/pnas.0711044105","article-title":"Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization","volume":"105","author":"Scheel","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2011.10.023_bb0285","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1128\/JVI.00080-06","article-title":"Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites","volume":"80","author":"Stiasny","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0290","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1473-3099(08)70126-9","article-title":"Hepatitis C vaccine: supply and demand","volume":"8","author":"Strickland","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2011.10.023_bb0295","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.21088","article-title":"Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33","volume":"43","author":"Tarr","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2011.10.023_bb0300","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/jvi.59.2.479-485.1986","article-title":"Relationship between poliovirus neutralization and aggregation","volume":"59","author":"Thomas","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0305","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1128\/JVI.80.4.1734-1741.2006","article-title":"Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry","volume":"80","author":"Tscherne","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0310","doi-asserted-by":"crossref","first-page":"10159","DOI":"10.1128\/JVI.01180-10","article-title":"Characterization of the envelope glycoproteins associated with infectious hepatitis C virus","volume":"84","author":"Vieyres","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.023_bb0315","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo","volume":"132","author":"von Hahn","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2011.10.023_bb0320","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/0042-6822(91)90104-J","article-title":"Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins","volume":"180","author":"Weiner","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.virol.2011.10.023_bb0325","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.virol.2007.05.038","article-title":"Cryo-electron microscopy and three-dimensional reconstructions of hepatitis C virus particles","volume":"367","author":"Yu","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virol.2011.10.023_bb0335","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM200012073432301","article-title":"Peginterferon alfa-2a in patients with chronic hepatitis C","volume":"343","author":"Zeuzem","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2011.10.023_bb0330","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa1013086","article-title":"Telaprevir for retreatment of HCV infection","volume":"364","author":"Zeuzem","year":"2011","journal-title":"N. Engl. J. Med."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682211005022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682211005022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:13:44Z","timestamp":1758586424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682211005022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0042682211005022"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2011.10.023","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2011.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}